Latest news
Collegium Pharmaceutical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 10:31:46 GMTCollegium Pharmaceutical: Pain Cash Flows Are Funding An ADHD Re-Rating (NASDAQ:COLL) - Seeking AlphaSeeking Alpha · Sat, 01 Aug 2026 07:00:00 GMT